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Abstract  26 
Background: Hajj is the annual mass gathering of Muslims, and is a reservoir and 27 
potential source of bacterial transmission. The emergence of bacterial transmission, 28 
including multi-drug resistance (MDR) bacteria, during Hajj has not been 29 
systematically assessed. 30 
Methods: Articles in Pubmed, Scopus, and Google scholar were identified using 31 
controlled words relating to antibiotic resistance (AR) at the Hajj from January 2002 32 
to January 2017. Eligible studies were identified by two researchers. AR patterns of 33 
bacteria were obtained for each study. 34 
Results: We included 31 publications involving pilgrims, Hajj workers or local 35 
patients attending hospitals in Mecca, Mina, and the Medina area. Most of these 36 
publications provided antibiotic susceptibility results. Ten of them used the PCR 37 
approach to identify AR genes. MRSA carriage was reported in pilgrims and food 38 
handlers at a rate of 20%. Low rates of vancomycin-resistant gram-positive bacteria 39 
were reported in pilgrims and patients. The prevalence of third-generation 40 
cephalosporin-resistant bacteria was common in the Hajj region. Across all studies, 41 
carbapenem-resistant bacteria were detected in fewer than 10% of E.coli isolates 42 
tested but up to 100% in K. pneumoniae and A. baumannii. Colistin-resistant 43 
Salmonella enterica, including mcr-1 colistin-resistant E.coli and K.pneumoniae were 44 
only detected in the pilgrim cohorts. 45 
Conclusion: This study provides an overview of the prevalence of MDR bacteria at 46 
the Hajj. Pilgrims are at high risk of AR bacterial transmission and may carry and 47 
transfer these bacteria when returning to their home countries. Thus, pilgrims should 48 
be instructed by health care practitioners about hygiene practices aiming at reducing 49 
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traveler’s diarrhea and limited use of antibiotics during travel in order to reduce the 50 
risk of MDR bacterial transmission. 51 
Keywords 52 
Hajj; multidrug resistant bacteria; pilgrims; bacterial carriage; bacterial transmission; 53 
systematic review; Saudi Arabia 54 
1. Introduction 55 
Hajj (pilgrimage to Mecca) is the largest annual mass gathering of Muslims with more 56 
than two million participants every year from more than 184 countries gathering in 57 
Saudi Arabia. During their journey, pilgrims visit the Holy Mosque in Mecca, stay in 58 
a tented camp in Mina and usually travel to Medina [1]. This mass gathering has a 59 
high potential for an outbreak due to the transmission of infectious diseases among 60 
pilgrims via person-to-person contact, contaminated foods or water, and the 61 
environment [1]. During the Hajj season, pilgrims are required to follow time-62 
sensitive religious rituals at specific times at different places simultaneously for a 63 
week. This intensely crowded situation has the potential for outbreaks of 64 
meningococcal disease [2], for the transmission of tuberculosis [3] other bacterial and 65 
viral respiratory tract infections [4] and for diarrheal diseases [5]. Additionally, many 66 
pilgrims travel to the Hajj in a group, sharing transport and accommodation including 67 
airlines and buses, food, tents, and toilets for a week, which constitutes an additional 68 
risk for transmission of communicable diseases. Nowadays, the global spread of 69 
antibiotic-resistant (AR) bacteria, such as extended spectrum beta-lactamase 70 
Enterobacteriaceae (ESBL-E), through international travelers is common [4,5]. The 71 
acquisition of carbapenem-resistant bacteria has also been described in travelers, 72 
including NDM-1 in travelers returning to the UK from India or KPC-producing 73 
bacteria in travelers returning to France from the United States [6]. AR bacteria are 74 
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prevalent in Saudi Arabia [7–11]. Hajj pilgrims therefore have the potential to 75 
disseminate or acquire AR bacteria during their stay in Saudi Arabia and to spread 76 
these bacteria when returning to their home country. Here, we review the available 77 
literature on the prevalence of major gram-positive and gram-negative AR bacteria 78 
isolated in pilgrims or other populations living in the area where pilgrims stay, 79 
including Mecca, Mina, and Medina. 80 
2. Methods 81 
We performed a systematic review according to the Preferred Reporting Items for 82 
Systematic Reviews and Meta-Analyses (PRISMA) guidelines 83 
(http://www.prismastatement.org). The electronic literature search was conducted in 84 
three electronic databases, Pubmed, Scopus, and Google Scholar, for articles about 85 
the emergence of antibiotic resistant bacteria during the Hajj. Searches were specified 86 
only in Hajj areas including Mecca, Mina, and Medina.  Papers published from 87 
January 2002 to January 2017 and written in English were included. MeSH terms 88 
included “Gram positive bacteria”, “Streptococcus”, “Staphylococcus”, 89 
“Enterococcus”, “Gram negative bacteria”, “Acinetobacter”, “Enterobacteriaceae”, 90 
“Campylobacter”, “Escherichia”, “Klebsiella”, “Neisseria”, “Pseudomonas”, 91 
“Salmonella”, “Shigella”, “Yersinia”, “methicillin”, “MRSA”, “vancomycin”, 92 
“VRSA”, “VRE”, “carbapenem”, “Extended spectrum”, “ESBL”, “colistin”, “drug 93 
resistant”, “ colonization”, “susceptibility”, “Hajj”, “pilgrims”, “Makkah”, “Mecca”, 94 
“Mina”, “Madinah”, and “Medina” (see Appendix). The search results were imported 95 
into the Mendeley references manager and de-duplicated. The articles were 96 
independently screened based on titles and abstracts by two researchers 97 
(Leangapichart and Gautret) and any discord was discussed between the two 98 
researchers. In addition, the Saudi epidemiology bulletin 99 
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(http://fetp.edu.sa/Bulletin.html) was hand searched for additional papers for 100 
inclusion. Studies were eligible for inclusion if they reported on phenotypic and/or 101 
genetic antibiotic resistance patterns and provided prevalence data. We excluded case 102 
reports. Reference lists of selected papers were screened to retrieve additional 103 
relevant studies. The following data were extracted from each study: year of study, 104 
geographical area, study setting, demographics, bacterial species investigated, and 105 
antibiotic resistance patterns. Prevalence of bacteria resistant to a given antibiotic was 106 
calculated from the number of AR bacteria divided by the total number of isolates 107 
tested. 108 
3. Results 109 
3.1 Study selection 110 
A total of 275 papers resulted from the initial search. After de-duplication, 185 studies 111 
were screened based on abstract content and 148 were excluded. Subsequently, 37 112 
full-text articles were assessed for eligibility and 31 were included in the qualitative 113 
synthesis of the systematic review with the first publication in July 2002 (Figure 1). 114 
Most of the publications provided antibiotic susceptibility results. Eleven of them 115 
used the PCR approach to identify AR genes. The main findings are presented in 116 
Tables 1 and 2.  117 
3.2 Studies conducted in pilgrims and Hajj workers (Table 1). 118 
A total of 14 publications were retrieved [12–25]. Studies were conducted during the 119 
Hajj season from 2000 through 2015. Most studies were conducted in Mecca and 120 
Medina, and one study was conducted in the Mina area. Study designs included cross-121 
sectional surveys enrolling ill pilgrims attending health care structures in Saudi 122 
Arabia and food handlers and kitchen workers from Mecca.  Other studies were 123 
prospective-cohort studies and were conducted in group of pilgrims before and after 124 
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participating in the Hajj or the Umrah. The number of individuals in each study varied 125 
from 80 to 374. Participants originated from different continents and countries (the 126 
Gulf region, Europe, Asia, Africa, America), with the majority from Saudi Arabia and 127 
France. Participants were selected through travel agencies, food facilities in Mecca 128 
and various Saudi health care structures. Studies conducted involving ill pilgrims 129 
included patients suffering from skin infections [12], respiratory tract infections [23] 130 
and urinary tract infections [25]. In two studies, the syndromic classification of 131 
infectious diseases was not documented [14,24]. Most samples were collected using 132 
nasal swabs (for respiratory pathogens), and rectal swabs (for intestinal pathogens). 133 
Clinical infections in ill pilgrims were documented in five studies while nine studies 134 
reported on asymptomatic bacterial carriage in pilgrims and Hajj workers (5 135 
respiratory carriage studies and 4 digestive carriage studies). Only one study analyzed 136 
risk factors for CTX-M acquisition by PCR detection in French pilgrims, during 137 
2013-2014 Hajj. Shortness of breath, diarrhea, and β-lactam use were significantly 138 
associated with high CTX-M acquisition. By contrast, the use of macrolide was 139 
associated with low CTX-M acquisition. 140 
3.2.1 Studies investigating MRSA colonization and resistant Streptococcus 141 
pneumoniae 142 
Several studies addressed oxacillin or methicillin-resistant Staphylococcus aureus 143 
(MRSA) carriage, starting from the 2000 Hajj.  144 
Ill pilgrims consulting hospitals during the Hajj 145 
The proportion of MRSA in positive isolates reported in patients varied according to 146 
the type of infection, reaching 2% in pilgrims suffering from pyoderma in 2000 [12], 147 
7% in patients suffering from various types of infection in 2004, 28% in pilgrims 148 
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suffering from sinusitis in 2014 and 63% in pilgrims with community acquired 149 
infections in 2015 [14,23,24].  150 
Cohorts of pilgrims and food handlers 151 
The acquisition of MRSA by pilgrims was also investigated through longitudinal 152 
surveys in 2009. The prevalence of MRSA among positive isolates was 15-20% in 153 
Hajj pilgrims and 10-11% in Umrah pilgrims with no significant difference before 154 
and after participating in the events [15]. Additionally, food handlers working in 155 
restaurants in Mecca were screened for MRSA carriage during the Hajj 2001-2002 156 
and 2014 resulting, respectively, in 0 and 20% MRSA identification in positive 157 
isolates [13,22]. One study addressed the carriage of resistant S. pneumoniae in a 158 
multinational cohort of pilgrims and showed that 23% of isolates were resistant to 159 
multiple antibiotics (resistant to three or more classes of antibiotics) [17]. 160 
3.2.2 Studies investigating ESBL colonization 161 
Cohorts of pilgrims  162 
Five studies were prospectively conducted in cohorts of French pilgrims before, 163 
during and after the Hajj with the aim of evaluating the carriage of resistant 164 
pathogens[16,18–21]. During the 2013 and 2014 Hajj seasons, studies were conducted 165 
using rectal and/or and nasal samples obtained before and after the Hajj. The 166 
prevalence of the blaCTX-M gene in rectal samples was 10% before-Hajj compared to 167 
33% after-Hajj in 2013 [18] and 7% before-Hajj compared to 34.83% after-Hajj in 168 
2014 [19]. There was also a significant increase in the number of pilgrims harboring 169 
E. coli which was resistant to ceftriaxone and ticarcillin-clavulanic acid [18].  170 
3.2.3 Studies investigating carbapenem-resistant bacteria colonization 171 
Cohorts of pilgrims  172 
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Screening of carbapenemase genes by qPCR in rectal samples of pilgrims before and 173 
after Hajj showed the acquisition of A. baumannii with blaOXA-72 and E. coli with 174 
blaNDM-5 in a French cohort traveling to the 2014 Hajj [21].  175 
Ill pilgrims consulting hospitals during the Hajj 176 
During the 2014-2015 Hajj, the blaCTX-M gene in E. coli isolates was reported among 177 
47% of pilgrims attending hospitals for urinary tract infections [25]. The 3GC-178 
resistant A. baumannii were observed at 91% during the 2014 Hajj [21] and 77% in ill 179 
pilgrims during the 2015 Hajj [24]. Overall, imipenem-resistant bacteria were 180 
reported during the 2014-2015 Hajj at a rate ranging from 1 to 90% in A. baumannii, 181 
E. coli, K. pneumoniae, and P. aeruginosa [21,23,24].  182 
3.2.4 Studies investigating colistin resistant bacteria colonization  183 
Cohorts of pilgrims  184 
Salmonella enterica which were resistant to ceftriaxone, gentamycin and colistin were 185 
isolated from two pilgrims [16]. Screening for the mcr-1 plasmid-mediated colistin 186 
resistance gene directly from rectal swabs was conducted in 2013 and 2014, and 187 
showed a prevalence of 1-2% before-Hajj and 9% after-Hajj. Rectal swabs from 188 
positive individuals allowed culturing mcr-1 producing E. coli and K. pneumoniae 189 
[20]. 190 
3.3 Studies conducted in patients attending hospitals in Mecca and Medina 191 
(Table 2). 192 
A total of 17 studies presented the prevalence of AR bacteria in local patients as 193 
shown in Table 2 [26–42]. Studies were conducted from 2003 through 2015. 194 
Fifteen studies were conducted in Mecca, while two studies were conducted in the 195 
Medina area. All studies were cross-sectional surveys conducted on patients attending 196 
general hospitals in Saudi Arabia and one was conducted on clinical isolates obtained 197 
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from clinical laboratories. The numbers of patients in each study varied from 43 to 198 
1,626 [26–42]. The patients’ origin was not documented in 12 studies. In studies with 199 
available data, the origin of patients was primarily Saudi Arabia. Studies were 200 
conducted on patients suffering from various diseases due to bacterial infection 201 
including skin infections [34], blood infections [28,36], digestive tract infections [27], 202 
and diarrhea [42]. The type of infection was not documented in most studies [26,29–203 
33,35,37,40,41]. Several types of samples were collected depending on the type of 204 
bacterial infection using wound swabs, ear swabs, eye swabs, blood, sputum, urine, 205 
and stool samples. Two studies did not document the type of samples used [35,39]. 206 
Six studies reported the prevalence of MRSA in septicemic patients, diabetic patients 207 
and patients with undocumented types of infections which ranged from 38.9-57.7% in 208 
2003-2015 [26,28,30,34,35]. Identification of the Panton-Valentine leucocidin (PVL) 209 
toxin by PCR was done in two studies, and PVL rose to 19% in 2012 [35] but was 0% 210 
in 2016 [40]. However, a later study reported the fnBPA-encoding gene in MRSA 211 
isolated from wound swabs at a rate of 8% and no vancomycin-resistant genes were 212 
detected in this study [40].  213 
One study conducted on patients belonging to 22 nationalities suffering from gram-214 
positive bacterial infections reported a low rate of vancomycin-resistant S. aureus 215 
(VRSA) at 2%, vancomycin-resistant Enterococcus faecalis at 3.5% and vancomycin-216 
resistant Enterococci (VRE) at 2%, but a high rate of ampicillin-resistant S. 217 
pneumoniae, at 21.1% [30]. Oxacillin-resistant coagulase-negative staphylococci 218 
(CoNS) were observed at a rate of 61% during 2004-2005, 82.4% during 2008-2009, 219 
and 93.6% during 2012-2013, mainly in patients with sepsis [28,30,36]. 220 
Some studies reported 3GC-resistant E.coli, K. pneumoniae, and A. baumannii in 221 
patients with different bacterial infections during 2005-2015, ranging from 18.8% to 222 
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94% [29,33,34,41]. ESBL genes, blaCTX-M, blaTEM, and blaSHV, were reported in two 223 
studies conducted in ICU patients. The proportion of blaCTX-M and blaTEM in E.coli 224 
and K. pneumoniae cases were similar at 18.5-30% but in A. baumannii was 71-81%, 225 
while the rate of blaSHV was 7.4% in E. coli, 17.2% in K. pneumoniae, and 0% in A. 226 
baumannii [31,38]. Overall, low rates of imipenem-resistant bacteria, E. coli and K. 227 
pneumoniae were reported to vary at around 4-11.9% during 2004-2015 [28,29,41]. A 228 
high prevalence of imipenem-resistant A. baumannii and P. aeruginosa were detected 229 
at varying rates of 4-60.5% and 4-43%, respectively. The prevalence of blaOXA-23 was 230 
identified in 91% in A. baumannii isolates, causing infection in ICU patients during 231 
2012-2013 [31]. The occurrence of metallo-β-lactamase genes among carbapenem-232 
resistant A. baumannii isolates during 2004-2014 was 11.5-27.1% carrying blaVIM and 233 
13.6% carrying blaIMP. For carbapenem-resistant P. aeruginosa isolated from patients, 234 
4.1-18.4% carried blaVIM and 4.7-21.0% carried blaIMP [31,32,37]. One study 235 
conducted on patients with peptic ulcer disease during 2003-2004 reported 31% of 236 
Helicobacter pylori isolates as being resistant to metronidazole and 3% resistant to 237 
tetracycline and erythromycin [27]. In addition, shiga toxin-producing E.coli was 238 
investigated in patients suffering from diarrhea in the Medina area. The report 239 
indicated significant associations between human and sheep isolates, with 70% of 240 
human isolates being resistant to trimethoprim/sulfamethoxazole [42].  241 
3.4 Assessment of antibiotic resistance patterns among bacterial isolates 242 
When data were pooled from the 30 published reports, AR patterns of 28 studies were 243 
compared between pilgrims and healthy participants during Hajj seasons and local 244 
patients attending hospitals in Mecca, Mina, and Medina. Two studies reported AR 245 
genes only using the PCR method. The reported rates of AR bacteria vary between 246 
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studies and hospitals. The comparisons of AR patterns were arranged by group of 247 
species and year of study (Figure 2-4). 248 
3.4.1 Antibiotic resistance in Gram-positive bacteria 249 
The prevalence and AR pattern of gram-positive bacteria isolated from pilgrims and 250 
Hajj workers, including local patients, drawn from 13 studies are presented in Figure 251 
2. The prevalence of resistance in patients with S. aureus isolated from Hajj seasons 252 
was <30% for oxacillin but up to 100% in general patients. VRSA was identified in 253 
six studies, of which one reported a 2% resistance rate in local patients. CoNS and 254 
Enterococcus sp. were not studied in pilgrims or Hajj workers but in patients from 255 
Hajj areas. Compared to CoNS Enterococcus sp., and Streptococcus sp., vancomycin 256 
was the most active agent with a resistance rate of 0-4%. The resistance rate of CoNS 257 
increased from 26% to 82% for gentamicin during 2004-2012; >70% for 258 
erythromycin; and >50% to 63% for clindamycin. The resistance rate of 259 
Streptococcus spp. isolates to amoxicillin/clavulanic acid in pilgrims and patients was 260 
1-7% and was 7-26% for penicillin.  261 
3.4.2 Antibiotic resistance in Enterobacteriaceae 262 
Twelve studies performed antibiotic susceptibility testing on E.coli, Klebsiella sp., 263 
Enterobacter sp., Salmonella sp., and Proteus sp. (Figure 3). 264 
Overall, resistance rates of E.coli in pilgrims and local patients were similar, varying 265 
from 5-100% for cephalosporins; <10% for imipenem, meropenem, and ertapenem; 266 
and 13-75% for gentamicin. Colistin-resistant E.coli was observed in one pilgrim 267 
study. Meanwhile, the occurrence of resistant Klebsiella sp. isolates among pilgrims 268 
and patients was high, at 16-64% for cephalosporins and 4-82% for imipenem. In 269 
addition, the resistance rate of Enterobacter sp. to ciprofloxacin and gentamicin was 270 
low at an early stage, but increased substantially during 2004-2015. Susceptibility 271 
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testing of Salmonella isolates was conducted in three studies. Most isolates were 272 
susceptible to many antibiotic groups, including amikacin, imipenem, and 273 
ciprofloxacin. 274 
3.4.3 Antibiotic resistance in non-Enterobacteriaceae 275 
The antibiotic resistance of A. baumannii isolated from pilgrims and local patients 276 
showed uniform resistance to cephalosporins with a resistance rate of 45-100%. 277 
Resistance patterns of A. baumannii to imipenem in patients or ill pilgrims ranged 278 
between 14-100% but were 2% in healthy pilgrims. However, the resistance rate of P. 279 
aeruginosa to imipenem decreased in local patients from 43% to 22%, from 42% to 280 
20% for amikacin, and from 61% to 27% for gentamicin during 2004-2015 (Figure 4). 281 
 282 
Discussion 283 
The prevalence of AR bacteria has increased significantly worldwide over the past 284 
two decades. International travelers have been known for years to experience 285 
alterations in gut microbiota due to the change of nutritional factors [43,44] and the 286 
acquisition of AR bacteria through the use of antibiotics during travel [4]. By 287 
attending the Hajj, millions of pilgrims present a source of infectious disease 288 
transmission [1,45,46]. Pilgrims attending Hajj are an important reservoir for the 289 
spread and transmission of AR bacteria. Many factors, such as crowded conditions, 290 
airborne/droplet transmission, and lack of efficient personal hygiene, diarrhea, and 291 
use of antimicrobial medications could be associated with the spread of AR bacteria. 292 
Our review indicates the prevalence and increasing rate of AR bacteria in the Hajj 293 
area include MRSA, 3GC-Enterobacteriaceae, imipenem-resistant bacteria, and 294 
colistin-resistant bacteria. Resistance rates varied between studies, although 295 
comparison was difficult due to differences in the antibiotics tested.  296 
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Community-acquired MRSA has been associated with closed settings involving lots 297 
of people and travelers [47]. In Saudi Arabia, the rates of MRSA varied between 298 
different regions ranging widely from 0.06% to 94%, in studies conducted during 299 
2002-2012 [48,49]. The personal hygiene of food-handlers and the sanitation of 300 
restaurants in Mecca were investigated in 2007, demonstrating that 67% of food-301 
handlers do not wear gloves and 45% have dirty fingernails [50]. It is not surprising 302 
that MRSA isolated from the food-handlers increased from 0 during 2001-2002 to 303 
20% during the 2014 Hajj [13,22] and to 63.2% in pilgrims during the 2015 Hajj. 304 
Cross contamination of bacteria from workers may occur between people through 305 
skin, hands and food. In addition, the presence of S. aureus in a water tank supplying 306 
the drinking water to private households’ in Mecca has also been reported. The poor 307 
condition of these water stations can result in poor water quality [51].  308 
Additionally, common diseases such as airborne transmission or respiratory tract 309 
infections are well-documented in pilgrims through the acquisition of respiratory 310 
viruses and bacteria [52], including S. pneumoniae, K. pneumoniae [53], and A. 311 
baumannii [21]. The possible effect of desert dust and other particles in the spread of 312 
airborne bacteria has been documented (24), which might be related to very common 313 
symptoms among pilgrims including the “Hajj cough” [54]. Several pilgrims have an 314 
increased rate of S. pneumoniae acquisition at the Hajj, rising from 1.2 times to 3.9 315 
times during 2011-2013 [17,52,55,56].  316 
Diarrhea is one of the most common problems among travelers, and is associated with 317 
the acquisition of ESBL bacteria. Twenty-one percent of travelers with ESBL 318 
acquisition had diarrhea [57]. ESBL-producing Enterobacteriaceae were detected in a 319 
single cohort study of pilgrims traveling to the 2013 Hajj, demonstrating the 320 
possibility that several bacterial species may carry CTX-M type ESBL genes [16,18].  321 
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A similar study was conducted on E.coli isolated from urinary tract infections in 322 
pilgrims attending hospital in Mecca during the 2014–2015 Hajj [25]. These two 323 
studies had the same circulating sequence type of E.coli, ST131 and ST648. The 324 
plasmid-mediated colistin resistance gene, mcr-1 was screened in pilgrims during 325 
2013-2014 and revealed the constant acquisition rate of mcr-1 at 9% at return [20]. 326 
This may suggest an identical source of bacterial transmission among pilgrims during 327 
the Hajj season. The spread of clones and specific types of AR genes might be related 328 
to travel destination and food vehicles contaminated by MDR bacteria [58]. Thus, the 329 
detection of AR genes in Mecca residents or environments related to pilgrims may be 330 
a useful way of investigating the source of AR bacterial transmission. One limitation 331 
of this study is the lack of data about diarrhea prevalence and use of antibiotics in 332 
most included studies, which does not allow evaluating their possible impact on the 333 
prevalence of AR bacterial related infection or carriage. 334 
Recently, our group reported CTX-M genes acquisition during the 2013 and 2014 335 
Hajj showing rates of acquisition at 31.0% and 34.8%, respectively [19]. Diarrhea and 336 
use of β-lactam antibiotics during the Hajj were demonstrated to be independent risk 337 
factors of CTX-M gene acquisition. Moreover, shortness of breath in pilgrims was 338 
associated with CTX-M-gene acquisition and macrolide use was shown to be an 339 
independent protective factor against CTX-M-gene acquisition [19]. Most of pilgrims 340 
traveling to Hajj carry antibiotics from their home country or obtained from over the 341 
counter in Saudi Arabia [59,60]. Pilgrims overuse or misuse of antibiotics ranged 342 
from 34.9% to 94.7% at the Hajj, which likely contributes to increased resistance 343 
[54,59–64].  344 
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One study reported the negative association between macrolides and CTX-M 345 
acquisition. Thus, restricted use of antibiotics during the Hajj should be highly 346 
recommended. 347 
In such a context, vaccination represents a key component in the fight against 348 
antibiotic resistance. Vaccination against bacterial pathogens or against viral agents 349 
including notably S. pneumoniae and influenza virus directly and indirectly reduces 350 
the need for antibiotics for both the control of primarily bacterial infections and super-351 
infection of viral diseases [65]. In addition, it has been well demonstrated that the 352 
conjugate vaccine against S. pneumoniae targets the most virulent serotypes 353 
associated with invasive pneumococcal diseases (IPD) that are also associated with 354 
antibiotic resistance [66–68]. These arguments reinforce the need for compliance with 355 
current recommendations for vaccinating at-risk Hajj pilgrims against IPD and 356 
influenza [69]. 357 
The date of the Hajj changes from year to year and will fall in the summer season for 358 
the next 10 years [70], which may provide a favorable environment for AR bacteria 359 
and the spread of infectious diseases. In this review, we presented the prevalence of 360 
AR bacterial acquisition in pilgrims, including the prevalence of AR bacteria in food 361 
workers and patients living in the Hajj area, which saw an increase over the 2000-362 
2015-period. In Hajj season, the number of food poisoning cases ranged from 44 to 363 
132 for the last 12 years [71]. Pilgrims may acquire AR bacteria from contaminated 364 
food during preparation or storage, unpasteurized dairy products, raw unpeeled fruit 365 
and vegetables, or contaminated water. Thus, the personal hygiene of kitchen staff 366 
including sanitary of food preparation area and storage should be improved and 367 
monitored to reduce the rate of the transmission of foodborne infections. Moreover, 368 
pilgrims coming from different countries with different cultures and life style are 369 
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exposed to crowded food outlets, toilets, and other accommodation and transportation 370 
facilities with different personal hygiene standards. Implementation of effective 371 
personal hygiene practices such as wearing a face mask, hand hygiene, can be 372 
effective approaches for reducing respiratory and digestive illness. Additionally, 373 
pilgrims should be instructed by travel medicine practitioners for guiding hygienic 374 
precautions, avoidance of diarrhea and unnecessary use of antibiotics before travels. 375 
Moreover, our review showed a high rate of resistance among gram-positive and 376 
negative bacteria including MRSA and 3GC-Enterobacteriaceae in local habitants; 377 
whereas, VRSA, VRE, carbapenem and colistin-resistant bacteria prevalence is still 378 
low. However, carbapenem resistance emergence in A. baumannii and P. aeruginosa 379 
is of concern in Mecca and Medina area.  In Saudi Arabia, antibiotics are easily 380 
obtained from over the counter without legislation or restrictions on their use [72], 381 
which may lead to increase AR bacteria prevalence. High rates of AR bacterial 382 
infection in patients hospitalized in Saudi Arabia is worrying and physicians attending 383 
patients in this area should be aware of the situation and undertake adapted isolation 384 
measures. Therefore, controlling inappropriate use of antibiotics is the key for 385 
reducing antibiotic resistance. Moreover, public educational campaigns to discourage 386 
the use of antibiotics should be promoted. This may include country or global-wide 387 
surveillance to monitor antibiotic consumption and resistance trends among local 388 
population and international travelers including Hajj pilgrims. 389 
 390 
 391 
 392 
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Figure legends 420 
Figure 1 Study selection. Flow diagram of identification and selection process 421 
included in systematic review. 422 
Figure 2 Antibiotic susceptibility patterns of gram-positive bacteria from in-Hajj and 423 
out-Hajj periods. Blue highlights indicate the study was conducted during Hajj 424 
seasons. Prevalence of bacteria resistant to a given antibiotic were calculated from the 425 
number of AR bacteria divided by the total number of isolates tested, red, ≥ 67%; 426 
orange, < 67% and ≥ 33%; green, <33% are highlighted.  Different numbers of 427 
isolates tested for resistance are marked with asterisk. 428 
Figure 3 Antibiotic susceptibility patterns of Enterobacteriaceae from in-Hajj and 429 
out-Hajj periods. Blue highlights indicate the study was conducted during Hajj 430 
seasons. Prevalence of bacteria resistant to a given antibiotic were calculated from the 431 
number of AR bacteria divided by the total number of isolates tested, red, ≥ 67%; 432 
orange, < 67% and ≥ 33%; green, <33% are highlighted. Different numbers of isolates 433 
tested for resistance are marked with asterisk. 434 
Figure 4 Antibiotic susceptibility patterns of Acinetobacter sp. and Pseudomonas 435 
aeruginosa from in-Hajj and out-Hajj periods. Blue highlights indicate the study was 436 
conducted during Hajj seasons. Prevalence of bacteria resistant to a given antibiotic 437 
were calculated from the number of AR bacteria divided by the total number of 438 
isolates tested, red, ≥ 67%; orange, < 67% and ≥ 33%; green, <33% are highlighted. 439 
Different numbers of isolates tested for resistance are marked with asterisk.440 
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Appendix A. Supplementary data 678 
Search strategy for the systematic review of the emergence of drug resistant 679 
bacteria at the Hajj 680 
Pubmed ((Gram positive[tiab] OR streptococc*[tiab] OR staphylo*[tiab] OR 681 
enterococc*[tiab] OR Gram negative[tiab] OR Acinetobact*[tiab] OR 682 
Enterobacteri*[tiab] OR Entero bacteria*[tiab] OR Enteric bacteria*[tiab] OR 683 
Enterobacter*[tiab] OR Escherichia*[tiab] OR e coli[tiab] OR Klebsiella*[tiab] OR 684 
Campylobacter*[tiab] OR Salmonell*[tiab] OR Shigell*[tiab] OR Yersinia*[tiab] OR 685 
Neisseria*[tiab] OR Pseudomonas*[tiab] OR methicillin*[tiab] OR MRSA*[tiab] OR 686 
vancomycin*[tiab] OR VRSA*[tiab] OR VRE*[tiab] OR carbapenem*[tiab] OR 687 
ESBL*[tiab] OR Extended spectrum*[tiab] OR colistin*[tiab])) AND ((resistan*[tiab] 688 
OR coloni*[tiab] OR ((antibiotic*[tiab] OR antimicrob*[tiab]) AND sensitivit*[tiab]) 689 
OR susceptib*[tiab])) AND (hadj*[tiab] OR hajj*[tiab] OR pilgrim*[tiab] OR 690 
Makkah[tiab] OR Mecca[tiab] OR Mina[tiab] OR Medina[tiab] OR Madinah[tiab]) 691 
 692 
Scopus TITLE-ABS-KEY ( ( ( "Gram positive" )  OR Streptococcus* OR  693 
Staphylococcus* OR Enterococ* OR ( ( "Gram negative"  OR  Acinetobacter*  OR  694 
enterobacteri*  OR  ( enter*  W/1  bacteria* ) )  OR  enterobacter*  OR  Escherichia*  695 
OR  "e coli"  OR  Klebsiella*  OR  Campylobacter*  OR  Salmonell* OR Shigell*  696 
OR  Yersinia*  OR  Neisseria* OR Pseudomonas* OR methicillin* OR MRSA* OR 697 
vancomycin* OR VRSA* OR VRE* OR carbapenem* OR Extended-spectrum* OR 698 
ESBL* OR colistin*))  AND (resistan* OR coloni* OR ((antibiotic* OR antimicrob*) 699 
W/3 sensitivit*) OR susceptib*) AND ( hadj*  OR  hajj*  OR  pilgrim*  OR  Makkah 700 
OR Mecca OR Mina OR Medina OR Madinah)) 701 
 702 
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Google Scholar “Gram positive”|Streptococcus|Staphylococcus|Enterococcus|“Gram 703 
negative”|Acinetobacter|Enterobacteriaceae|Escherichia|Klebsiella|Campylobacter|Sal704 
monella|Shigella|Yersinia|Neisseria|Pseudomonas|methicillin|MRSA|vancomycin|VR705 
SA|VRE|carbapenem|“Extended spectrum”|ESBL|colistin|antibiotic 706 
resistance|resistant|colonization|colonisation|susceptibility|Hadj|Hajj|pilgrim|Makkah|707 
Mecca|Mina|Medina|Madinah  708 
 709 
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Table 1. Prevalence of antibiotic resistance bacteria in 13 studies conducted in pilgrims and Hajj workers 710 
 711 
Period/Year Geographical 
area 
Study design Samples Country of origin Microbiological 
techniques 
Number of 
individuals with 
positive 
culture/number 
of individual 
tested (%) 
Bacteria or gene 
investigated 
Number of 
individuals with 
resistant bacteria/ 
No. of individuals 
with positive 
culture (%) 
Number of 
individuals with 
resistant bacteria/ 
number of 
individual tested 
(%) 
References 
Hajj 2000 
and 2001 
Mecca Cross-sectional 
survey conducted 
in 80 ill pilgrims 
attending the 
dermatology clinic 
for pyoderma at 
King Faisal 
Hospital 
Skin lesion 
swabs 
Saudi Arabia (46.3%), 
Asia (26.3%), Arabian 
Peninsula (non-Saudi 
Arabia) (26.2%), and 
Europe (1.2%) 
Culture and 
AST 
47/80 (58.8) Methicillin resistant 
Staphylococcus aureus 
(MRSA) 
1/47 (2.1) 1/80 (1.3) Fatani et al., 
2002 [12] 
Hajj 2001 
and 2002 
Mecca Cross-sectional 
survey conducted 
on 428 food 
handlers  
Nasal swabs, 
throat swabs, 
nail swabs, 
stool samples, 
and wound 
swabs when 
available 
No data Culture and 
AST 
45/428 (10.5) Enterotoxins producer 
MRSA 
0/45 (0) 0/428 (0) Dablool and 
Al-Ghamdi, 
2011 [13] 
Hajj 2004 Mina Cross-sectional 
survey conducted 
on 411 ill pilgrims 
attending the 
National Guard 
Health Affairs 
facility for medical 
reason 
Nasal, axilla, 
groin and open 
wound swabs 
when available 
Saudi Arabia (59.3%), 
Egypt (17.3%), 
Pakistan (6.2%), 
Yemen (3.7%), Sudan 
(8.7%), India (2.5%), 
Chad (2.5%), Others 
(6.2%) 
Culture, AST, 
PCR 
85/411 (20.7) MRSA  
 
6/85 (7.1) 
 
6/411(1.5) Memish et al., 
2006 [14] 
Umrah 2009 Mecca Longitudinal survey 
conducted on 979 
pilgrims before and 
after the Umrah 
Nasal swabs Turkey (13.2%), 
Indonesia (13%), 
Pakistan (10.4%), 
Syria (10%), Nigeria 
(10%), Egypt (8%), 
Iran (7.9%), UK 
(5.7%), Iraq (5.7%), 
Malaysia (4%), Libya 
(2.8%), Sweden 
(1.4%), US (0.4%), 
Jordan (0.1%) 
Culture and 
AST 
155/979 (15.8) 
before and 
235/979 (24.0) 
after 
MRSA 16/155 (10.3) 
before and 
25/235 (10.6) 
after 
16/979 (1.6) before 
and 25/979 (2.6) 
Johargy et al., 
2011 [15] 
Hajj 2009 Mecca Longitudinal survey 
conducted on 613 
pilgrims before and 
after the Hajj 
Nasal swabs India (26.3%), Nigeria 
(16.6%), Indonesia 
(15.5%), Libya 
(14.7%), Syria (11%), 
UK (7.5%), Turkey 
(5.7%), Australia 
(1.8%), Sweden 
Culture and 
AST 
153/613 (25.0) 
before 
and128/613 
(20.9) after 
MRSA 30/153 (19.6) 
before and 
19/128 (14.8) 
after  
30/613 (4.9) before 
and 19/613 (3.1) 
after 
Johargy et al., 
2011 [15] 
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(0.5%) and Iran 
(0.3%) 
Hajj 2013 Mecca, Mina 
and Medina 
Longitudinal survey 
conducted on 129 
pilgrims before and 
after the Hajj 
Rectal 
samples  
France Culture, AST, 
PCR 
screening 
0/129 (0.0) 
before and 
5/129 (3.9) 
after 
ESBL and colistin-resistant 
Salmonella enterica 
2/5 (40.0) after 2/129 (1.6) after Olaitan et al., 
2015 [16] 
Hajj 2013 Mecca and 
Mina 
Longitudinal survey 
conducted on 
1,175 pilgrims 
before and 1,155 
pilgrims after the 
Hajj 
Nasal swabs 12 countries in Africa, 
Asia, USA, and 
Europe 
Culture and 
AST, MLST 
110/1175 (9.4) Multidrug-resistant S. 
pneumoniae 
25/110 (22.7) 25/1175 (2.1) Memish et al., 
2016 [17] 
Hajj 2013 Mecca, Mina 
and Medina 
Longitudinal survey 
conducted on 129 
pilgrims, before 
and after the Hajj 
 
Rectal 
samples  
France Culture*, AST, 
MLST, PCR 
screening in 
samples 
18/129 (14.0) 
before and 
36/129 (27.9) 
after 
CRO-resistant E.coli  
 
 
Ticarcillin-clavulanic-
resistant E. coli 
 
PCR screening of AR gene 
-CTX-M  
5/18 (27.8) before 
and 18/36 (50.0) 
after  
5/18 (27.8) before 
and 13/36 (36.1) 
after 
13/129 (10.1) 
before and 
42/129 (32.1) 
after 
5/129 (3.9) before 
and 18/129 (14.0) 
after 
5/129 (3.9) before 
and 13/129 (10.1) 
after 
13/129 (10.1) 
before and 42/129 
(32.1) after 
Leangapichart 
et al., 2016 [18] 
Hajj 2014 Mecca, Mina 
and Medina 
Longitudinal survey 
conducted on 129 
pilgrims (2013); 98 
pilgrims (2014) 
before, during and 
after the Hajj 
Rectal 
samples 
France PCR 
screening in 
samples 
7/89 (7.87) 
before and 
31/89 (34.83) 
after 
PCR screening of AR gene 
-CTX-M 
7/89 (7.87) before 
and 31/89 (34.83) 
after 
7/89 (7.87) before 
and 31/89 (34.83) 
after 
Leangapichart 
et al., 2016 [19] 
Hajj 2013 
and Hajj 
2014 
Mecca, Mina 
and Medina 
Longitudinal survey 
conducted on 129 
pilgrims (2013); 98 
pilgrims (2014) 
before, during and 
after the Hajj  
Rectal 
samples  
France PCR 
screening of 
AR gene in 
samples, 
culture, AST, 
and MLST 
 
- PCR screening of AR gene 
-mcr-1 colistin resistance 
gene 
2013: 2/129 (1.6) 
before and 
11/129 (8.53) 
after, 2014: 1/92 
1.0) before and 
9/90 (9.2) after 
2013: 2/129 (1.6) 
before and 11/129 
(8.53) after, 2014: 
1/92 1.0) before 
and 9/90 (9.2) after 
Leangapichart 
et al., 2016 [20] 
Hajj 2014 Mecca, Mina 
and Medina 
Longitudinal survey 
conducted on 98 
pilgrims (98 
pilgrims before; 90 
pilgrims after the 
Hajj) 
Pharyngeal 
and rectal 
swabs 
collected 
before and 
after Hajj 
France Culture, PCR 
screening in 
samples, AST, 
and MLST 
A.baumannii*0/
98 before (0) 
and 43/90 
(47.8) after  
 
 
 
CRO-resistant A.baumannii 
 
 
 
PCR screening of AR gene  
-OXA-72 A.baumannii  
-NDM-5 E.coli 
39/43 (90.6)  
 
 
 
 
1/90 (1.1)  
1/90 (1.1)  
39/90 (43.3) 
 
 
 
 
1/90 (1.1)  
1/90 (1.1) 
Leangapichart 
et al., 2016 [21] 
Hajj 2014  Mecca Cross-sectional 
survey conducted 
on 200 male 
workers from 50 
kitchens 
Nasal and 
hand skin 
swabs 
No data Culture and 
PCR 
165/200 (40.3) MRSA 
 
33/165 (20.0)  33/200 (16.5) Ahmed and   
Mashat, 2014 
[22] 
Hajj 2014 Mecca Cross-sectional 
survey conducted 
on 226 pilgrims 
Sinus 
secretion 
swabs under 
GULF (58%), Asian 
(12.4%), South Asia 
(11.9%), North Africa 
Culture and 
AST 
46/226 (20.4) MRSA 
IMP-resistant K.pneumoniae 
13/46 (28.3) 
3/14 (21.4) 
13/226 (5.8) 
3/226 (1.3) 
Marglani et al., 
2016 [23] 
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• Cefotaxime and Cepacia selective medium 712 
• AST; Antibiotic susceptibility test 713 
 714 
 715 
716 
with acute  
rhinosinusitis 
attending Alnoor 
Specialized 
Hospital 
endoscopic 
guidance 
(11.5%), Africa 
(3.5%), Europe 
(2.2%), and American 
(0.5%) 
January to 
June 2015 
Mecca Cross-sectional 
survey conducted 
on 374 ill pilgrims 
with community- 
acquired infections 
attending Al-Noor 
Specialist Hospital 
and Ajyad 
Emergency 
Hospital 
Urine, blood, 
sputum 
Saudi Arabia (47.3%), 
Pakistan (8%), Egypt 
(6.4%), Bangladesh 
(4%), Yemen (6.7%), 
Myanmar (5.3%), 
Nigeria (2.1%), 
Indonesia (3.5%), 
Indian (3.5%), and 
others (13.1%) 
Culture and 
AST 
57/374 (15.2) MRSA 
ESBLs-E. coli 
Ceftazidime-resistant A. 
baumannii 
IMP-resistant E.coli 
IMP-resistant K.pneumoniae 
IMP-resistant A.baumannii 
IMP-resistant P.aeruginosa 
36/57 (63.2) 
4/107 (3.7) 
16/21 (76.2) 
 
3/107 (2.8) 
5/6 (83.3%) 
9/10 (90.0) 
5/45 (1.1) 
36/374 (9.6) 
4/374 (1.1) 
16/374 (4.3) 
 
3/374 (0.8) 
5/374 (1.3) 
9/374 (2.4) 
5/374 (1.3) 
Haseeb et al., 
2016 [24] 
Hajj 2014 
and 2015 
Mecca Cross-sectional 
survey conducted 
on 58 E.coli 
isolates from 
pilgrims suffering 
urinary tract 
infection attending 
two different 
general hospitals, 
which tried to be 
consistent and to 
present all studies 
in a similar way 
Urine No data Culture, AST, 
PCR, and 
MLST 
58 E.coli carrying AR genes 
-CTX-M 
-TEM 
-SHV 
-OXA-1 
-aac6 
 
27/58 (46.5) 
22/58 (37.9) 
2/58 (3.2) 
28/58 (48.3) 
26/58 (44.8) 
 
27/58 (46.5) 
22/58 (37.9) 
2/58 (3.4) 
28/58 (48.3) 
26/58 (44.8) 
Alyamani et al., 
2017 [25] 
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Table 2. Prevalence of antibiotic resistance bacteria in 17 studies conducted in patients hospitalized in Mecca and the Medina area.  717 
Period/Year Geographical 
area 
Study design Samples Country of origin Microbiological 
techniques 
Number of 
individuals with 
positive culture 
(or number of 
positive 
isolates)/number 
of individual 
tested (or total 
number of 
isolates) (%) 
Bacteria or gene investigated Number of 
individuals with 
resistant bacteria 
(or number of 
positive isolates / 
No. of individuals 
with positive 
culture (or total 
number of 
isolates) (%) 
Number of 
individuals with 
resistant 
bacteria/ 
number of 
individual tested 
(%) 
References 
April 2003 to 
March 2004 
Mecca Cross-sectional survey 
conducted on 512 S. 
aureus clinical isolates 
from hospitalized 
patients attending  
Al-Noor, King Abdul-
Aziz, Hera and King 
Faisal hospitals 
Wound swabs, 
ear swabs, eye 
swabs, blood, 
urine, respiratory 
tract 
No data Culture and 
AST 
512/512 (100.0) MRSA 
 
199/512 (38.9) 
 
199/512 (38.9) Asghar and 
Momenah, 
2006 [26] 
 
January 2003 to 
February 2004 
Mecca Cross-sectional survey 
conducted on 132 
patients with peptic 
ulcer disease attending 
Hera General Hospital 
Multiple biopsies 
from gastric 
antrum and 
fundus, 
duodenum 
Saudi Arabia 
(97.7%) others 
(2.3%) 
Culture and 
AST 
132/132 (100.0) Metronidazole-resistant 
Helicobacter pylori 
Tetracycline and erythromycin 
resistant H. pylori 
41/132 (31.0) 
 
4/132 (3.0) 
41/132 (31.0) 
 
4/132 (3.0) 
Karima 2006 
[27] 
April 2004 to 
March 2005 
Mecca Cross-sectional survey 
conducted on 1,626 
patients with sepsis 
attending Al-Noor, King 
Abdul-Aziz, Hera, and 
King Faisal hospitals 
Blood Saudi Arabia 
(62.2%) others 
(37.8%) 
Culture and 
AST 
1530/1626 
(94.1) 
Oxacillin-resistant CoNS 
MRSA 
IMP-resistant E.coli 
IMP-resistant Klebsiella sp. 
IMP-resistant Acinetobacter sp. 
IMP-resistant Pseudomonas sp. 
245/402 (61.0) 
161/303 (53.0) 
7/148 (5.0) 
4/109 (4.0) 
18/127 (4.0) 
61/142 (43.0) 
245/1626 (15.1) 
161/1626 (9.9) 
7/1626 (0.4) 
4/1626 (0.2) 
18/1626 (1.1) 
61/1626 (3.8) 
Asghar 2006 
[28] 
October 2005 to 
March 2006  
Mecca Cross-sectional survey 
conducted on 1,137 
clinical isolates from 
965 patients attending 
Al-Noor and Hera 
hospitals 
Different sites of 
infection; urinary 
tract infection, 
respiratory tract 
infection, wound 
infection, 
septicemia, 
female genital 
infection, and 
other infections 
No data Culture and 
AST 
1137/1137 
(100.0) 
CRO-resistant E.coli  
CRO-resistant K.pneumoniae  
IMP-resistant E.coli 
IMP-resistant K.pneumoniae 
 
28/149 (18.8) 
11/148 (22.9) 
6/74 (8.1) 
1/11 (9.1) 
28/965 (2.9) 
11/965 (1.1) 
6/965 (0.6) 
1/965 (0.1) 
Asghar and 
Faidah, 2009 
[29] 
 
May 2008 to 
April 2009 
Mecca Cross-sectional survey 
conducted on 1,087 
patients with gram-
positive bacterial 
infection attending Al-
Noor, Hera, and King 
Abdul-Aziz Hospitals 
Different sites of 
infection; urinary 
tract infection, 
respiratory tract 
infection, wound 
infection, 
septicemia/blood 
culture, female 
genital infection, 
and ear/eye 
22 different 
countries: Saudi 
Arabia (81%), 
Pakistan (4.4%), 
Yemen (2.0%), 
Nigeria (1.9%), 
Egypt (1.7%), 
others (9%) 
Culture and 
AST 
1087/1087 
(100.0) 
Oxacillin-resistant CoNS 
MRSA 
VRSA 
Ampicillin-resistant S. 
pneumoniae 
E. faecalis VRE 
Enterococcus spp. VRE 
85/97 (82.4) 
271/688 (39.4) 
9/441 (2.0) 
4/19 (21.1) 
 
1/149 (2.0) 
3/86 (3.5) 
85/1087 (7.8) 
271/1087 (24.9) 
9/1087 (0.8) 
4/1087 (0.4) 
 
1/1087 (0.09) 
3/1087 (0.3) 
Asghar 2011 
[30] 
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infections 
September 
2009 to March 
2010 
Mecca Cross-sectional survey 
conducted on 509 
clinical isolates from 
313 ICU patients 
attending Al-Noor, 
Hera, and King Abdul-
Aziz Hospitals 
Urine, wound 
swabs, and 
other sample 
types 
Saudi Arabia 
(50.9%), Pakistan 
(8.8%), India 
(5.9%), Egypt 
(5.7%) and Yemen 
(5.1%) 
Culture, AST, 
PCR 
509/509 (100.0) E.coli carrying AR genes 
-CTX-M 
-TEM 
-SHV 
K.pneumoniae carrying AR 
genes 
-CTX-M 
-TEM 
-SHV 
P.aeruginosa carrying AR genes 
-VIM 
-IMP 
-VIM&IMP 
A.baumannii carrying AR genes 
-VIM 
-IMP 
-VIM&IMP 
 
10/54 (18.5) 
10/54 (18.5) 
4/54 (7.4) 
 
 
35/116 (30.1) 
22/116 (19.0) 
20/116 (17.2) 
 
6/148 (4.1) 
7/148 (4.7) 
2/148 (1.4) 
 
22/191 (11.5) 
26/191 (13.6) 
6/191 (3.1) 
 
10/313 (3.2) 
10/313 (3.2) 
4/313 (1.3) 
 
 
35/313 (11.1) 
22/313 (7.0) 
20/313 (6.4) 
 
6/313 (1.9) 
7/313 (2.2) 
2/313 (0.6) 
 
22/313 (7.0) 
26/313 (8.3) 
6/313 (1.9) 
Asghar 2012 
[31] 
September 
2009 to March 
2010  
Mecca Cross-sectional survey 
conducted on 478 
clinical isolates from 
365 ICU patients 
attending Al-Noor, 
Hera, and King Abdul-
Aziz hospitals 
Sputum, wound 
swabs, and urine 
Saudi Arabia 
(64%), Pakistan 
(7.1%), Egypt 
(5.0%), Yemen 
(3.3%), India 
(3.1%), and 
Nigeria (1.9%) 
Culture, AST, 
PCR 
478/478 (100.0) MBL-producing P. aeruginosa 
carrying AR genes  
-IMP 
-VIM 
-IMP&VIM 
33/76 (43.4) 
 
16/76 (21.0) 
14/76 (18.4) 
3/76 (3.9) 
33/365 (9.0) 
 
16/365 (4.4) 
14/365 (3.8) 
3/365 (0.8) 
Asghar 2012 
[32] 
 
February-April 
2011 
Mecca  Cross-sectional survey 
conducted on 43 
hospitalized patients 
attending Al-Noor, 
Hera, Maternity and 
Children, King Abdul 
Aziz, and King Faisal 
hospitals 
Sputum, 
endotracheal 
tube secretion, 
tracheal 
aspiration, 
wound swabs, 
urine, and blood 
No data Culture and 
AST 
43/43 (100.0) IMP-resistant A.baumannii 
CTX-resistant A. baumannii 
 
26/43 (60.5) 
28/43 (65.1) 
 
26/43 (60.5) 
28/43 (65.1) 
 
Khan et al., 
2012 [33] 
June 2011 to 
June 2012 
Mecca Cross-sectional survey 
conducted on 138 
diabetic patients 
attending Umm Al-Qura 
University 
Foot infection 
and urinary tract 
infection 
samples 
No data Culture and 
AST 
129/138 (93.5) CTX-resistant E.coli 
MRSA 
 
15/27 (55.6) 
15/26 (57.7) 
15/138 (10.9) 
15/138 (10.9) 
Johargy 
2016 [34] 
March to 
September 
2012 
Mecca Cross-sectional survey 
conducted on 206 S. 
aureus isolates 
collected from five 
major tertiary-care 
hospitals 
No data No data Culture and 
PCR 
206/206 (100.0) MRSA carrying AR genes 
mecA 
PVL 
 
100/206 (48.5) 
19/100 (19.0) 
 
100/206 (48.5) 
19/206 (9.2) 
Asghar 2014 
[35] 
January 2012 to 
October 2013 
Mecca Cross-sectional survey 
conducted on 190 
Coagulase-negative 
Staphylococci (CoNS) 
isolates from neonatal 
septicemia patients 
Blood No data Culture and 
AST 
190/190 (100.0) Oxacillin-resistant CoNS 
 
178/190 (93.6) 178/190 (93.6) Khan et al., 
2014 [36] 
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• AST; Antibiotic susceptibility test 718 
719 
attending Maternity and 
Children Hospital 
2014 (4 month-
period) 
Medina Cross-sectional survey 
conducted on 48 
patients attending out-
patients clinic at King 
Fahd Hospital  
Wound swabs, 
sputum, urine, 
blood 
No data AST and PCR 48/48 (100.0) A.baumannii carrying VIM-1 13/48 (27.1) 13/48 (27.1) El-Ageery 
and  
Al-Hazmi, 
2014 [37] 
2012 to 2014 Mecca Cross-sectional survey 
conducted on 107 
clinical isolates from 
ICU patients attending 
local general hospitals 
Blood, and skin 
wound infection  
No data Culture, AST, 
PCR, MLST 
107/107 (100.0) ESBLs-A. baumannii 
A. baumannii carrying AR genes 
-CTX-M 
-TEM 
-SHV 
-OXA-51 
-OXA-23 
100/107 (94.0) 
 
87/107 (81.0) 
73/107 (71.0) 
0/107 (0.0) 
100/107 (94.0) 
97/107 (91.0) 
100/107 (94.0) 
 
87/107 (81.0) 
73/107 (71.0) 
0/107 (0.0) 
100/107 (94.0) 
97/107 (91.0) 
Alyamani et 
al., 2015 [38] 
August 2013 to 
January 2014 
Mecca Cross-sectional survey 
conducted on 64 P. 
aeruginosa clinical 
isolates from patients at 
Al-Noor and Maternity 
and Children hospitals 
Respiratory 
surgical, genital 
samples, urine, 
blood, ear 
swabs, eye 
swabs, burn 
swabs 
No data Culture and 
AST 
64/64 (100.0) IMP-resistant P.aeruginosa 14/64 (21.9) 14/64 (21.9) Khan and 
Faiz, 2016 
[39] 
No data Mecca Cross-sectional survey 
conducted on 50 S. 
aureus clinical isolates 
from clinical 
laboratories 
Blood cultures, 
wound swabs, 
urine, nasal 
swabs, and 
sputum  
No data Culture, AST, 
PCR 
50/50 (100.0) MRSA carrying AR genes 
mecA 
fnBPA 
PVL 
van gene 
 
11/50 (22.0) 
4/50 (8.0) 
0/50 (0.0) 
0/50 (0.0) 
 
11/50 (22.0) 
4/50 (8.0) 
0/50 (0.0) 
0/50 (0.0) 
Abulreesh et 
al., 2016 [40] 
January to July 
2015 
Mecca Cross-sectional survey 
conducted on 260 K. 
pneumoniae clinical 
isolates from patients at 
Al-Noor, King Faisal, 
King Abdul Aziz, Hera, 
and Maternity and 
Children hospitals 
No data No data Culture and 
AST 
260/260 (100.0) CRO-resistant K. pneumoniae 
IMP-resistant K. pneumoniae 
111/260 (42.7) 
31/260 (11.9) 
111/260 (42.7) 
31/260 (11.9) 
Khan and 
Faiz, 2016 
[41] 
June and 
August 2015 
Medina Cross-sectional survey 
conducted on 134 
patients suffering from 
diarrhea attending 
Ouhud Hospital  
Stool samples No data Culture and 
AST 
30/134 (22.4) Shiga toxin-producing E.coli 
resistant to 
Trimethoprim/Sulfamethoxazole 
 
21/30 (70.0 
 
21/134 (15.7) Sharaf and 
Shabana, 
2016 [42] 
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Figure 1 Study selection. Flow diagram of identification and selection process included in systematic review.  720 
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 Figure 2 Antibiotic susceptibility patterns of gram-positive bacteria from in-Hajj and out-Hajj periods. Blue highlights indicate the study was 721 
conducted during Hajj seasons. Prevalence of bacteria resistant to a given antibiotic were calculated from the number of AR bacteria divided by 722 
the total number of isolates tested, red, ≥ 67%; orange, < 67% and ≥ 33%; green, <33% are highlighted. Different numbers of isolates tested for 723 
resistance are marked with asterisk. 724 
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Staphylococcus aureus
Fatani et al., 2002 [12] 47 6 13 4 4 2 81 2 4
Dablool and Al-Ghamdi, 2011 [13] 45 0 4 2 0 0 100 4 7
Asghar and Momenah, 2006 (MRSA) [26] 199 85 90 85 100 100 100 100 0 80
Asghar and Momenah, 2006 (MSSA) [26] 313 10 19 14 83 0 96 5 0 9
Memish et al., 2006 [14] 85 7 7
Asghar, 2006 [28] 303 44 56 48 79 53 92 38 49 42 0 58
Asghar, 2011 [30] 1-688* 60 36 0 50 42 34 8 32 5 92 63 39 93 42 64 31 30 24 25 51 22 60 33 23 2 38 26 100 46 6 36 27 17 21
Johargy et al., 2011 (Umrah) [15] 235 3 4 19 0 11 10 11 0 1 88 11 11 0 0 11 3 4 3 0 2
Johargy et al., 2011 (Makkah) [15] 128 9 10 49 0 25 22 20 0 0 79 15 15 0 0 22 12 20 10 0
Johargy, 2016 [34] 26 54 54 54 58 58 100 77 50 54 62 100 58
Abulreesh et al., 2016 [40] 50 6 16 10 12 10 18 0 100 22 100 16 22 18 0 0 0 0 0 0 0
Marglani et al., 2016 (MRSA) [23] 13 46 39 77 92 31 100 100 100 100 100 100 100 100 0 54 62 69
Marglani et al., 2016 (MSSA) [23] 33 3 18 18 21 9 39 21 0 0 0 3 0 15 0 0 12 12
Haseeb et al., 2016 (MRSA) [24] 5-24* 42 78 91 75 87 84 30 80 60 67 50 60 72 50 63 0 42
Haseeb et al., 2016 (MSSA) [24] 7-17* 91 24 89 29 0 0 0 0 0 0 43 40 0 40 0
Coagulase-negative staphylococci
Asghar, 2006 [28] 402 26 72 50 72 61 91 34 49 26 0 75
Asghar, 2011 [30] 1-86* 91 63 100 36 83 63 0 50 87 95 82 90 60 92 56 67 71 71 89 80 50 100 50 3 0 47 50 80 11 60 64 27 0
Khan et al., 2014 [36] 190 82 78 78 60 2 0 99 94 100 93 0 2
Enterococcus spp.
Asghar, 2006 [28] 78 95 83 98 23 96 84 11 98 95 0 98
Asghar, 2011 [30] 1-99* 2 48 0 78 44 60 50 0 14 15 0 9 12 79 0 64 50 50 67 60 33 33 50 20 4 0 93 50 38 100 33 71 33 4
Asghar, 2011 (E.faecalis ) [30] 1-56* 0 83 0 94 65 83 75 0 0 27 50 0 33 25 0 0 67 0 100 50 0 0 0 100 2 0 86 67 56 0 61 50 50 0
Streptococcus spp.
Fatani et al., 2002 (Streptococcus pyrogenes ) [12] 24 0 0
Asghar, 2006 (Streptococcus spp ) [28] 70 89 26 24 13 27 26 1 23 33 0 79
Asghar, 2006 (Streptococcus pneumoniae ) [28] 44 89 16 9 7 16 7 5 14 18 0 68
Asghar, 2011 (Streptococcus pneumoniae ) [30] 1-19* 100 70 0 33 17 39 100 0 0 21 100 67 20 7 100 25 8 13 17 8 13 100 0 0 20 0 70 0 100 50 67 0 100 100
Asghar, 2011 (Streptococcus pyrogenes ) [30] 1-12* 56 60 17 13 33 14 50 78
Memish et al., 2016 [17] 110 56 25 13 6 8 0 0 0 48 1 1
Haseeb et al., 2016 (Streptococcus spp ) [24] 3-15* 0 20 0 36 75 0 0 100
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Figure 3 Antibiotic susceptibility patterns of Enterobacteriaceae from in-Hajj and out-Hajj periods. Blue highlights indicate the study was conducted during 725 
Hajj seasons. Prevalence of bacteria resistant to a given antibiotic were calculated from the number of AR bacteria divided by the total number of isolates 726 
tested, red, ≥ 67%; orange, < 67% and ≥ 33%; green, <33% are highlighted. Different numbers of isolates tested for resistance are marked with asterisk. 727 
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Escherichia coli
Asghar, 2006 [28] 148 17 43 89 55 70 9 76 38 43 20 45 5 35 65
Asghar and Faidah, 2009 [29] 40-316* 11 26 22 56 84 59 52 9 58 12 36 15 25 19 30 8 1 49 46 32 39 53 59 12
Asghar, 2012 [31] 22-52* 47 70 83 91 67 47 91 28 56 54 53 46 55 52 6 4 58 44 72 32
Johargy, 2016 [34] 9-27* 0 30 50 100 11 78 59 67 56 50 100 67 56 6
Sharaf and Shabana, 2016 [42] 30 13 57 47 77 33 23 17 70
Marglani et al., 2016 [23] 8 0 75 0 0 0 0 0 0 0 0 0 13
Leangapichart et al., 2016 (a) (ESBL) [18] 18 28 0 72 100 0 0
Leangapichart et al., 2016 (b) (mcr-1 ) [20] 10 40 100 100 40 10 20 20 100 30 10 60
Haseeb et al., 2016 [24] 3-100* 7 28 57 84 100 59 97 40 24 45 31 34 41 49 3 75 60 44 100 63
Haseeb et al., 2016 (ESBL) [24] 4 75 75 0 0 0 0 75
Alyamani et al., 2017 [25] 58 97 5 76 81 75 90 0 0 80
K. pneumoniae
Asghar, 2006 (Klebsiella sp .) [28] 109 42 54 96 68 62 8 76 32 61 18 60 4 26 67
Asghar and Faidah, 2009 (Klebsiella sp .) [29] 2-65* 21 32 36 67 99 44 44 7 37 19 60 33 32 42 37 9 47 34 56 57 50 52 32
Asghar and Faidah, 2009 [29] 4-85* 10 25 20 86 95 54 29 10 38 16 38 23 32 23 34 9 42 32 39 33 50 37 27
Asghar, 2012 [31] 30-106* 51 61 100 84 71 47 78 44 62 63 64 56 60 73 13 17 53 43 64 75
Khan and Faiz., 2016 [41] 260 29 43 31 12 12
Leangapichart et al., 2016 (ESBL) [18] 5 40 0 60 100 0 0
Leangapichart et al., 2016 (mcr-1 ) [20] 1 100 100 100
Marglani et al., 2016 [23] 14 0 100 40 40 0 0 0 0 20 0 0 0
Haseeb et al., 2016 [24] 6-63* 5 38 46 94 52 17 67 43 20 35 23 24 0 27 23 82 10 13 41 0 44 55
Enterobacter spp.
Asghar, 2006 [28] 19 5 16 84 26 89 11 95 84 26 0 26 0 0 32
Asghar and Faidah, 2009 [29] 1-19* 8 39 67 95 50 100 20 100 90 100 46 56 47 57 9 33 67 24 29
Haseeb et al., 2016 (E.clocae ) [24] 4-9* 50 0 75 84 0 100 100 0 0 0 0 0 0 45 0
Salmonella enterica
Asghar, 2006 (Salmonella  spp .) [28] 11 0 9 55 36 36 0 27 0 0 0 0 0 0 64
Olaitan et al., 2015 [16] 5 0 40 0 0 60 40 40 40 40 0 40 0 0 0
Haseeb et al., 2016 [24] 4 0 0 0 0 0 0 0 0 0 0 0
Proteus spp.
Asghar, 2006 [28] 12 25 17 83 42 58 0 75 67 8 0 17 8 25 33
Asghar and Faidah, 2009 [29] 3-36* 27 43 86 53 19 32 33 33 16 29 33 7 12 6 80 17 4 50 67
Haseeb et al., 2016 (P. mirabilis ) [24] 6-16* 34 75 88 50 100 23 70 58 60
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Figure 4 Antibiotic susceptibility patterns of Acinetobacter sp. and Pseudomonas aeruginosa from in-Hajj and out-Hajj periods. Blue highlights 728 
indicate the study was conducted during Hajj seasons. Prevalence of bacteria resistant to a given antibiotic were calculated from the number of 729 
AR bacteria divided by the total number of isolates tested, red, ≥ 67%; orange, < 67% and ≥ 33%; green, <33% are highlighted. Different 730 
numbers of isolates tested for resistance are marked with asterisk. 731 
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Acinetobacter baumannii
Asghar, 2006 (Acinetobacter sp. ) [28] 127 75 72 97 73 87 8 98 92 79 45 90 14 77 76
Asghar and Faidah, 2009 [29] 1-106* 84 76 57 97 93 43 100 98 100 83 87 97 95 46 28 33 71 64 75 83
Asghar, 2012 [31] 107-183* 93 81 99 95 97 93 87 93 96
Khan et al., 2012 [33] 43 54 44 65 65 95 74 65 58 58 72 61 61 63
El-Ageery and Al-Hazmi, 2014 [37] 48 90 81 100 100 71 94 100 100 100 96 100 100
Leangapichart et al., 2016 [21] 43 0 2 2 37 74 40 100 49 91 93 2 0 5 7 5 0
Haseeb et al., 2016 [24] 3-24* 67 46 50 100 100 0 100 77 77 90 64 0 83 67
Pseudomonas aeruginosa
Fatani et al., 2002 [12] 5 0 0 0 0 0 0 0
Asghar, 2006 [28] 142 42 61 89 34 82 10 87 76 44 22 56 43 24 73
Asghar and Faidah, 2009 [29] 16-339* 48 50 54 73 70 49 77 34 76 73 53 83 58 39 20 96 51 58 44 75 77 96
Asghar, 2012 [31] 62-139* 47 55 44 57 63 69 44 53 60
Asghar, 2012 [32] 90-464* 32 42 32 97 47 94 41 97 94 94 78 51 70 52 50 29 36 43 92
Khan and Faiz, 2016 [39] 64 20 27 28 30 8 20 11 23 22 42 22 27
Haseeb et al., 2016 [24] 3-45* 12 21 0 75 100 59 33 0 95 36 34 11 17 49 0 0 100
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